{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:01:25Z","timestamp":1790676085917,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Diabetes has become one of the major noninfectious diseases that seriously endanger public health. The formation of islet amyloid polypeptide (IAPP) affects the normal physiological functions of the body, such as glucose metabolism and lipid metabolism. The mature human IAPP protein (hIAPP) has a strong tendency to misfold and is considered to be one of the major causes of amyloid changes in islets. Deposition of hIAPP is considered to be one of the leading causes of type 2 diabetes mellitus (T2DM). Miniature pigs are experimental animal models that are well suited for research on gene function and human diabetes. In our study, we obtained <jats:italic>IAPP<\/jats:italic> gene-humanized miniature pigs via the CRISPR\/Cas9 system and somatic cell nuclear transfer (SCNT) technology. The hIAPP pigs can be used to further study the pathogenesis and related complications of T2DM and to lay a solid foundation for the prevention and treatment of T2DM.<\/jats:p>","DOI":"10.1038\/s41419-019-2056-5","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:09:44Z","timestamp":1572260984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Preparation of a new type 2 diabetic miniature pig model via the CRISPR\/Cas9 system"],"prefix":"10.1038","volume":"10","author":[{"given":"Xiaodong","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsheng","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengzhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"2056_CR1","unstructured":"Miley, D. D. & Terezhalmy, G. T. The patient with diabetes mellitus: etiology, epidemiology, principles of medical management, oral disease burden, and principles of dental management. Quintessence Int. 36, 779\u2013795 (2005)."},{"key":"2056_CR2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"ERF Collaboration","year":"2011","unstructured":"Collaboration, E. R. F. Diabetes mellitus, fasting glucose, and risk of cause-specific death. New Engl. J. Med. 364, 829\u2013841 (2011).","journal-title":"New Engl. J. Med."},{"key":"2056_CR3","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nrendo.2011.183","volume":"8","author":"L Chen","year":"2012","unstructured":"Chen, L., Magliano, D. J. & Zimmet, P. Z. The worldwide epidemiology of type 2 diabetes mellitus\u2014present and future perspectives. Nat. Rev. Endocrinol. 8, 228 (2012).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2056_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.diabres.2009.10.006","volume":"87","author":"G Roglic","year":"2010","unstructured":"Roglic, G. & Unwin, N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res. Clin. Pract. 87, 15\u201319 (2010).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"2056_CR5","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"AD Association","year":"2013","unstructured":"Association, A. D. Diagnosis and classification of diabetes mellitus. Diabetes Care 36, S67\u2013S74 (2013).","journal-title":"Diabetes Care"},{"key":"2056_CR6","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1021\/cr5002832","volume":"115","author":"GR Kokil","year":"2015","unstructured":"Kokil, G. R., Veedu, R. N., Ramm, G. A., Prins, J. B. & Parekh, H. S. Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics. Chem. Rev. 115, 4719\u20134743 (2015).","journal-title":"Chem. Rev."},{"key":"2056_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00125-004-1625-y","volume":"48","author":"T Drivsholm","year":"2005","unstructured":"Drivsholm, T., de Fine Olivarius, N., Nielsen, A. B. S. & Siersma, V. Symptoms, signs and complications in newly diagnosed type 2 diabetic patients, and their relationship to glycaemia, blood pressure and weight. Diabetologia 48, 210\u2013214 (2005).","journal-title":"Diabetologia"},{"key":"2056_CR8","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.jdiacomp.2016.05.004","volume":"30","author":"A Meijnikman","year":"2016","unstructured":"Meijnikman, A. et al. Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score. J. Diabetes Complic. 30, 1043\u20131049 (2016).","journal-title":"J. Diabetes Complic."},{"key":"2056_CR9","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.2337\/db07-0882","volume":"56","author":"MT Hamilton","year":"2007","unstructured":"Hamilton, M. T., Hamilton, D. G. & Zderic, T. W. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56, 2655\u20132667 (2007).","journal-title":"Diabetes"},{"key":"2056_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1542\/peds.105.3.671","volume":"105","author":"AD Association","year":"2000","unstructured":"Association, A. D. Type 2 diabetes in children and adolescents. Pediatrics 105, 671\u2013680 (2000).","journal-title":"Pediatrics"},{"key":"2056_CR11","doi-asserted-by":"crossref","unstructured":"Ginter, E. & Simko, V. Diabetes 42\u201350 (Springer, 2013).","DOI":"10.1007\/978-1-4614-5441-0_6"},{"key":"2056_CR12","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/diab.39.5.634","volume":"39","author":"SE Kahn","year":"1990","unstructured":"Kahn, S. E. et al. Evidence of cosecretion of islet amyloid polypeptide and insulin by \u03b2-cells. Diabetes 39, 634\u2013638 (1990).","journal-title":"Diabetes"},{"key":"2056_CR13","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1210\/me.2004-0407","volume":"19","author":"L Marzban","year":"2005","unstructured":"Marzban, L., Trigo-Gonzalez, G. & Verchere, C. B. Processing of pro-islet amyloid polypeptide in the constitutive and regulated secretory pathways of \u03b2 cells. Mol. Endocrinol. 19, 2154\u20132163 (2005).","journal-title":"Mol. Endocrinol."},{"key":"2056_CR14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0167-0115(96)02109-X","volume":"68","author":"R Gasa","year":"1997","unstructured":"Gasa, R., Gomis, R., Casamitjana, R. & Novials, A. Signals related to glucose metabolism regulate islet amyloid polypeptide (IAPP) gene expression in human pancreatic islets. Regulatory Pept. 68, 99\u2013104 (1997).","journal-title":"Regulatory Pept."},{"key":"2056_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/019262301301418955","volume":"29","author":"JD Wagner","year":"2001","unstructured":"Wagner, J. D. et al. Naturally occurring and experimental diabetes in cynomolgus monkeys: a comparison of carbohydrate and lipid metabolism and islet pathology. Toxicol. Pathol. 29, 142\u2013148 (2001).","journal-title":"Toxicol. Pathol."},{"key":"2056_CR16","doi-asserted-by":"publisher","first-page":"E1317","DOI":"10.1152\/ajpendo.00082.2006","volume":"291","author":"JJ Meier","year":"2006","unstructured":"Meier, J. J. et al. Inhibition of human IAPP fibril formation does not prevent \u03b2-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP. Am. J. Physiol. Endocrinol. Metab. 291, E1317\u2013E1324 (2006).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"2056_CR17","doi-asserted-by":"crossref","unstructured":"Pithadia, A., Brender, J. R., Fierke, C. A. & Ramamoorthy, A. Inhibition of IAPP aggregation and toxicity by natural products and derivatives. J. Diabetes Res. 2016, 12 (2016).","DOI":"10.1155\/2016\/2046327"},{"key":"2056_CR18","unstructured":"Grimm, J., Heitz, F., Wirth, F. & Welt, T. Novel compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose tolerance (Google Patents, 2018)."},{"key":"2056_CR19","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1152\/physiol.00003.2018","volume":"33","author":"N Javeed","year":"2018","unstructured":"Javeed, N. & Matveyenko, A. V. Circadian etiology of type 2 diabetes mellitus. Physiology 33, 138\u2013150 (2018).","journal-title":"Physiology"},{"key":"2056_CR20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/MOL.0000000000000383","volume":"28","author":"F Liao","year":"2017","unstructured":"Liao, F., Yoon, H. & Kim, J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease. Curr. Opin. Lipidol. 28, 60 (2017).","journal-title":"Curr. Opin. Lipidol."},{"key":"2056_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27\u201368 (2017).","journal-title":"Annu. Rev. Biochem."},{"key":"2056_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep44041","volume":"7","author":"DCR Camargo","year":"2017","unstructured":"Camargo, D. C. R. et al. The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes. Sci. Rep. 7, 44041 (2017).","journal-title":"Sci. Rep."},{"key":"2056_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.molmed.2015.04.005","volume":"21","author":"A Mukherjee","year":"2015","unstructured":"Mukherjee, A., Morales-Scheihing, D., Butler, P. C. & Soto, C. Type 2 diabetes as a protein misfolding disease. Trends Mol. Med. 21, 439\u2013449 (2015).","journal-title":"Trends Mol. Med."},{"key":"2056_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tim.2011.11.002","volume":"20","author":"F Meurens","year":"2012","unstructured":"Meurens, F., Summerfield, A., Nauwynck, H., Saif, L. & Gerdts, V. The pig: a model for human infectious diseases. Trends Microbiol. 20, 50\u201357 (2012).","journal-title":"Trends Microbiol."},{"key":"2056_CR25","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1017\/S0954422416000020","volume":"29","author":"E Roura","year":"2016","unstructured":"Roura, E. et al. Critical review evaluating the pig as a model for human nutritional physiology. Nutr. Res. Rev. 29, 60\u201390 (2016).","journal-title":"Nutr. Res. Rev."},{"key":"2056_CR26","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1034\/j.1600-051X.1999.260601.x","volume":"26","author":"MA Weinberg","year":"1999","unstructured":"Weinberg, M. A. & Bral, M. Laboratory animal models in periodontology. J. Clin. Periodontol. 26, 335\u2013340 (1999).","journal-title":"J. Clin. Periodontol."},{"key":"2056_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/ijbs.3.179","volume":"3","author":"JK Lunney","year":"2007","unstructured":"Lunney, J. K. Advances in swine biomedical model genomics. Int. J. Biol. Sci. 3, 179 (2007).","journal-title":"Int. J. Biol. Sci."},{"key":"2056_CR28","unstructured":"Pond, W. G., Church, D. C., Pond, K. R. & Schoknecht, P. A. Basic Animal Nutrition and Feeding. (John Wiley & Sons, 2004)."},{"key":"2056_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1017\/S0954422410000077","volume":"23","author":"P Guilloteau","year":"2010","unstructured":"Guilloteau, P., Zabielski, R., Hammon, H. M. & Metges, C. C. Nutritional programming of gastrointestinal tract development. Is the pig a good model for man? Nutr. Res. Rev. 23, 4\u201322 (2010).","journal-title":"Nutr. Res. Rev."},{"key":"2056_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1464-5491.2005.01499.x","volume":"22","author":"D Rees","year":"2005","unstructured":"Rees, D. & Alcolado, J. Animal models of diabetes mellitus. Diabet. Med. 22, 359\u2013370 (2005).","journal-title":"Diabet. Med."},{"key":"2056_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1111\/j.1476-5381.2012.01911.x","volume":"166","author":"AJ King","year":"2012","unstructured":"King, A. J. The use of animal models in diabetes research. Br. J. Pharmacol. 166, 877\u2013894 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"2056_CR32","doi-asserted-by":"crossref","unstructured":"Caillon, L., Hoffmann, A. R., Botz, A. & Khemtemourian, L. Molecular structure, membrane interactions, and toxicity of the islet amyloid polypeptide in type 2 diabetes mellitus. J. Diabetes Res. 2016, 13 (2016).","DOI":"10.1155\/2016\/5639875"},{"key":"2056_CR33","doi-asserted-by":"publisher","first-page":"928","DOI":"10.2174\/1567205011666141107124538","volume":"11","author":"J N. Fawver","year":"2014","unstructured":"N. Fawver, J. et al. Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease. Curr. Alzheimer Res. 11, 928\u2013940 (2014).","journal-title":"Curr. Alzheimer Res."},{"key":"2056_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2174\/157339913804143225","volume":"9","author":"Z Fu","year":"2013","unstructured":"Fu, Z., R Gilbert, E. & Liu, D. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes. Curr. Diabetes Rev. 9, 25\u201353 (2013).","journal-title":"Curr. Diabetes Rev."},{"key":"2056_CR35","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1021\/ar200189b","volume":"45","author":"JR Brender","year":"2011","unstructured":"Brender, J. R., Salamekh, S. & Ramamoorthy, A. Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc. Chem. Res. 45, 454\u2013462 (2011).","journal-title":"Acc. Chem. Res."},{"key":"2056_CR36","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1016\/j.bbamem.2007.01.022","volume":"1768","author":"SA Jayasinghe","year":"2007","unstructured":"Jayasinghe, S. A. & Langen, R. Membrane interaction of islet amyloid polypeptide. Biochim. Biophys. Acta 1768, 2002\u20132009 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"2056_CR37","doi-asserted-by":"publisher","first-page":"6424","DOI":"10.1021\/ja710484d","volume":"130","author":"JR Brender","year":"2008","unstructured":"Brender, J. R. et al. Amyloid fiber formation and membrane disruption are separate processes localized in two distinct regions of IAPP, the type-2-diabetes-related peptide. J. Am. Chem. Soc. 130, 6424\u20136429 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"2056_CR38","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s00125-008-1255-x","volume":"52","author":"S Zraika","year":"2009","unstructured":"Zraika, S. et al. Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis. Diabetologia 52, 626\u2013635 (2009).","journal-title":"Diabetologia"},{"key":"2056_CR39","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/BF00402271","volume":"36","author":"E De Koning","year":"1993","unstructured":"De Koning, E., Bodkin, N., Hansen, B. & Clark, A. Diabetes mellitus in Macaca mulatta monkeys is characterised by islet amyloidosis and reduction in beta-cell population. Diabetologia 36, 378\u2013384 (1993).","journal-title":"Diabetologia"},{"key":"2056_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.2337\/diacare.39.1.118","volume":"39","author":"C Betsholtz","year":"1990","unstructured":"Betsholtz, C. et al. Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes 39, 118\u2013122 (1990).","journal-title":"Diabetes"},{"key":"2056_CR41","doi-asserted-by":"publisher","first-page":"200a","DOI":"10.1016\/j.bpj.2010.12.1308","volume":"100","author":"J Zhao","year":"2011","unstructured":"Zhao, J., Yu, X., Zhao, C., Wang, Q. & Zheng, J. Molecular dynamics simulations of human islet amyloid polypeptide (IAPP) oligomers and their interactions with lipid bilayers. Biophys. J. 100, 200a\u2013201a (2011).","journal-title":"Biophys. J."},{"key":"2056_CR42","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/ilar.47.3.225","volume":"47","author":"AV Matveyenko","year":"2006","unstructured":"Matveyenko, A. V. & Butler, P. C. Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. ILAR J. 47, 225\u2013233 (2006).","journal-title":"ILAR J."},{"key":"2056_CR43","doi-asserted-by":"publisher","first-page":"T1","DOI":"10.1530\/JOE-14-0202","volume":"222","author":"RW Nelson","year":"2014","unstructured":"Nelson, R. W. & Reusch, C. E. Classification and etiology of diabetes in dogs and cats. J. Endocrinol. 222, T1\u2013T9 (2014).","journal-title":"J. Endocrinol."},{"key":"2056_CR44","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/13506129.2011.627956","volume":"18","author":"JF Paulsson","year":"2011","unstructured":"Paulsson, J. F., Benoit-Biancamano, M.-O., Sch\u00e4ffer, L. & Dahl, K. Ferret islet amyloid polypeptide (IAPP): characterization of in vitro and in vivo amyloidogenicity. Amyloid 18, 222\u2013228 (2011).","journal-title":"Amyloid"},{"key":"2056_CR45","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF00399947","volume":"36","author":"L Christmanson","year":"1993","unstructured":"Christmanson, L. et al. Islet amyloid polypeptide in the rabbit and European hare: studies on its relationship to amyloidogenesis. Diabetologia 36, 183\u2013188 (1993).","journal-title":"Diabetologia"},{"key":"2056_CR46","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1007\/BF03402051","volume":"6","author":"GT Westermark","year":"2000","unstructured":"Westermark, G. T., Gebre-Medhin, S., Steiner, D. F. & Westermark, P. Islet amyloid development in a mouse strain lacking endogenous islet amyloid polypeptide (IAPP) but expressing human IAPP. Mol. Med. 6, 998\u20131007 (2000).","journal-title":"Mol. Med."},{"key":"2056_CR47","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/eci.12370","volume":"45","author":"SJ Li","year":"2015","unstructured":"Li, S. J. et al. Development of a dietary\u2010induced metabolic syndrome model using miniature pigs involvement of AMPK and SIRT 1. Eur. J. Clin. Investig. 45, 70\u201380 (2015).","journal-title":"Eur. J. Clin. Investig."},{"key":"2056_CR48","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1079\/9781845937560.0426","volume":"2","author":"KN Kuzmuk","year":"2011","unstructured":"Kuzmuk, K. N. & Schook, L. B. Pigs as a model for biomedical sciences. Genet. Pig 2, 426\u2013444 (2011).","journal-title":"Genet. Pig"},{"key":"2056_CR49","doi-asserted-by":"publisher","first-page":"261","DOI":"10.4244\/EIJV6I2A42","volume":"6","author":"T Thim","year":"2010","unstructured":"Thim, T. et al. Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies. EuroIntervention 6, 261\u2013268 (2010).","journal-title":"EuroIntervention"},{"key":"2056_CR50","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/01.mpa.0000147083.62501.4e","volume":"30","author":"D Dufrane","year":"2005","unstructured":"Dufrane, D., Goebbels, R., Fdilat, I., Guiot, Y. & Gianello, P. Impact of porcine islet size on cellular structure and engraftment after transplantation: adult versus young pigs. Pancreas 30, 138\u2013147 (2005).","journal-title":"Pancreas"},{"key":"2056_CR51","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1242\/dev.121.1.11","volume":"121","author":"Y Guz","year":"1995","unstructured":"Guz, Y. et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121, 11\u201318 (1995).","journal-title":"Development"},{"key":"2056_CR52","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4161\/isl.1.2.9480","volume":"1","author":"A Kim","year":"2009","unstructured":"Kim, A. et al. Islet architecture: a comparative study. Islets 1, 129\u2013136 (2009).","journal-title":"Islets"},{"key":"2056_CR53","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1124\/pr.108.000604","volume":"60","author":"W Kim","year":"2008","unstructured":"Kim, W. & Egan, J. M. The role of incretins in glucose homeostasis and diabetes treatment. Pharmacol. Rev. 60, 470\u2013512 (2008).","journal-title":"Pharmacol. Rev."},{"key":"2056_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02785-y","volume":"7","author":"Z Xie","year":"2017","unstructured":"Xie, Z. et al. Optimization of a CRISPR\/Cas9-mediated knock-in strategy at the porcine Rosa26 locus in porcine foetal fibroblasts. Sci. Rep. 7, 3036 (2017).","journal-title":"Sci. Rep."},{"key":"2056_CR55","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s11248-017-0044-z","volume":"26","author":"K Wang","year":"2017","unstructured":"Wang, K. et al. CRISPR\/Cas9-mediated knockout of myostatin in Chinese indigenous Erhualian pigs. Transgenic Res. 26, 799\u2013805 (2017).","journal-title":"Transgenic Res."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2056-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:46:18Z","timestamp":1671212778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-2056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":55,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["2056"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-2056-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"2 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}],"article-number":"823"}}